Papers

2

Total Citations

12

H-Index

2

About

Dr. Haixiao Diao is a leading thoracic surgeon whose research focuses on optimizing minimally invasive surgical techniques for early-stage non-small cell lung cancer (NSCLC). His major contributions center on comparing functional recovery outcomes between robot-assisted thoracoscopic surgery (RATS) and uniportal video-assisted thoracoscopic surgery (VATS). In his 2023 propensity score-matched study, Dr. Diao demonstrated that three-port robot-assisted lobectomy offers superior early functional recovery over uniportal VATS, a finding that has already garnered 8 citations and influenced clinical practice. He extended this work in 2025 with a similar comparison for segmentectomy, showing that triportal RATS provides enhanced precision and flexibility, leading to better postoperative recovery. With a growing citation impact, Dr. Diao’s research is helping to establish evidence-based guidelines for choosing between robotic and video-assisted approaches in NSCLC treatment. His work is notable for its rigorous methodology and direct relevance to improving patient outcomes, making him a key voice in the evolution of thoracic surgery toward more refined, recovery-focused techniques.

Research Focus

Key Achievements

2
H-Index
2
Papers
12
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Comparison Results of Three-Port Robot-Assisted and Uniportal Video-Assisted Lobectomy for Functional Recovery Index in the Treatment of Early Stage Non-small Cell Lung Cancer: A Propensity Score-Matched Analysis
8 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Shandong University, Chinese Academy of Medical Sciences & Peking Union Medical College

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago